Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Continuous daily dosing of sunitinib in patients with advaned gastrointestinal stromal tumor (GIST)[abstract]

Continuous daily dosing of sunitinib in patients with advaned gastrointestinal stromal tumor (GIST)[abstract]. Connective Tissue Oncology Society. 2006; 648.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.